Table: Kidswell Bio - 9-MTH group results
Feb 12 (Reuters)-
Kidswell Bio Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2025 Dec 31, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 5.02 3.04
(+65.3 pct)
Operating 84 mln loss 137 mln
Recurring loss 134 mln loss 161 mln
Net loss 142 mln loss 187 mln
EPS loss 2.94 yen loss 4.69 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Kidswell Bio Corporation.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4584.T